Here is a collection of tweets from major companies in the cardiovascular devices market segment, as well as #GMedTechCardioVascular.
A healthy diet can decrease heart disease risk, but for most Americans taste, price and convenience drive food choice. We’re uniting experts from across the food ecosystem to increase access to affordable, healthy foods. Learn more: http://spr.ly/6019OjvqT
Jiangsu-based Zhenyi Medical(臻亿医疗) closes over CNY100M new series financing led by Proxima Ventures(比邻星创投), Anhui Life Sciences Fund (安徽生命健康基金), and C&D Investment(建发新兴投资).
#GMedTechFinancing
#GMedTechChina
#GMedTechCardioVascular
臻亿医疗完成超亿元人民币新一轮融资 - G-MedTech资讯中心
将持续推动心血管高端介入平台打造
www.g-medtech.com
Teleflex Launches New Arrow® VPS Rhythm® DLX Device and NaviCurve™ Stylet in the U.S., engineered to work together to give Vascular Access Specialists more efficient and predictable PICC placement.
#GMedTechUSA
#GMedTechCardioVascular
https://www.g-medtech.com/news/teleflex-launches-new-arrow-vps-rhythm-dlx-device-and-navicurve-stylet-in-the-u-s/